Our findings demonstrate a statistically significant increase in the expression of IL-1β, IL-6, and RIPK3 in the skin biopsy samples of SJS/TEN patients compared to those of lichen planus (LP) patients and normal controls. This evidence concerns the gene IL6 and toxic epidermal necrolysis.